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CORRECTION Open Access
Correction to: Gabapentin as add-on
to morphine for severe neuropathic or
mixed pain in children from age 3 months
to 18 years - evaluation of the safety,
pharmacokinetics, and efficacy of a new
gabapentin liquid formulation: study
protocol for a randomized controlled trial
Thomas G. de Leeuw1*, Laura Mangiarini2, Rebecca Lundin3, Florentia Kaguelidou4,5,6, Tjitske van der Zanden7,
Oscar Della Pasqua8, Dick Tibboel7, Adriana Ceci2, Saskia N. de Wildt7,9 and on behalf of the GAPP consortium
Correction to: Trials (2019) 20:49.
https://doi.org/10.1186/s13063-018-3169-3
Following publication of the original article [1], we
have been notified that the tagging of one of the author
names was done incorrectly in the XML version of the
paper. Original and corrected tagging can be seen below.
 Incorrect name tagging:
Last Name: Pasqua.
First Name: Oscar Della.
 Correct author name tagging:
Last Name: Della Pasqua.
First Name: Oscar.
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